Primary ovarian insufficiency secondary to chemotherapy with inotuzumab ozogamicin and other agents.
Primary ovarian insufficiency secondary to chemotherapy with inotuzumab ozogamicin and other agents. J Assist Reprod Genet. 2022 Aug; 39(8):1733-1738.